Clinical Trial Update: Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating efficacy and safety for cough and acute rhinitis in children aged 2-12 was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Inflammation, Cough | Phase 3 | Status: WITHDRAWN